Pila Pharma Q1’22: New project revealed - Redeye

Redeye leaves its comment on Pila Pharma following the announcement of its Q1 report. Highlights include revealing a new pipeline candidate and certification of API. The financials were broadly in line with expectations.

Länk till analysen i sin helhet: https://www.redeye.se/research/839230/pila-pharma-q122-new-project-revealed?utm_source=finwire&utm_medium=RSS